Equity Analysis

Quarterly Results

    Lupin Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500257
    INE326A01037
    451.6295136
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    LUPIN
    36.43
    99735.61
    EPS(TTM)
    Face Value()
    Div & Yield %:
    60.02
    2
    0.37
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales4084.003331.723999.47
Other Operating Income83.6364.16116.28
Other Income 38.2231.3423.16
Total Income4205.853427.224138.91
Total Expenditure 2967.962695.532898.41
PBIDT1237.89731.691240.50
Interest 13.5513.4911.36
PBDT1224.34718.201229.14
Depreciation141.42290.04145.18
Tax189.1969.06184.61
Fringe Benefit Tax0.000.000.00
Deferred Tax4.55-24.98-17.09
Reported Profit After Tax889.18384.08916.44
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item889.18384.08916.44
EPS (Unit Curr.)19.518.4320.14
EPS (Adj) (Unit Curr.)19.518.4320.14
Calculated EPS (Unit Curr.)19.508.4320.13
Calculated EPS (Adj) (Unit Curr.)19.508.4320.13
Calculated EPS (Ann.) (Unit Curr.)78.0133.7180.50
Calculated EPS (Adj) (Ann.) (Unit Curr.)78.0133.7180.50
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity91.1991.1491.07
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)30.3121.9631.02
PBDTM(%)29.9821.5630.73
PATM(%)21.7711.5322.91
Dividend Per Share(Rs)0.000.000.00
Diluted EPS19.518.4020.05